Disease/Infection News

RSS

FDA approves OZURDEX implant for uveitis treatment

Allergan, Inc. today announced that the United States Food and Drug Administration (FDA) has approved OZURDEX (dexamethasone intravitreal implant) 0.7 mg for the treatment of non-infectious ocular inflammation, or uveitis, affecting the posterior segment of the eye.

27 Sep 2010

WA teenage death related to swine flu

Teenager Andrew Allan died hours after being sent home from Northam Hospital, Western Australia (WA) with some Paracetamol by a nurse on the 17th September. He was ill with fever and vomiting but was not assessed by a doctor. Health officials now believe his illness was due to swine flu and are urging people to get vaccinated. Nine people have died from swine flu in WA this year.

26 Sep 2010

Key pathway used by malaria parasite to infect human cells identified

Development of an effective vaccine for malaria is a step closer following identification of a key pathway used by the malaria parasite to infect human cells. The discovery, by researchers at The Walter and Eliza Hall Institute in Melbourne, Australia, provides a new vaccine target through which infection with the deadly disease could be prevented.

24 Sep 2010

Enobia announces positive results from ENB-0040 Phase II juvenile clinical trial for hypophosphatasia

Enobia Pharma today announced positive results for its Phase II juvenile clinical trial of ENB-0040 (asfotase alfa), an experimental bone-targeted enzyme replacement therapy intended for the treatment of hypophosphatasia (HPP). Hypophosphatasia is a rare, inherited, and sometimes fatal metabolic bone disease that affects individuals of all ages.

24 Sep 2010

Gore completes enrollment in study of VIABAHN Endoprosthesis with Heparin Bioactive Surface

W. L. Gore & Associates (Gore) reported the complete enrollment in a post-market approval study designed to better characterize the performance of the GORE VIABAHN Endoprosthesis with Heparin Bioactive Surface in treating peripheral vascular disease (PVD) of the superficial femoral artery (SFA). The 11 participating sites enrolled a total of 120 patients in the Gore VIPER (GORE® VIABAHN® Endoprosthesis with Heparin Bioactive Surface for SuPERficial Femoral Artery Endoluminal Bypass) Study since initiation.

24 Sep 2010

3M announces series of educational events to combat healthcare-associated infections

As a company on a mission to help hospitals fight healthcare-associated infections (HAIs), 3M Infection Prevention today announced a series of educational events taking place the week of September 27.

24 Sep 2010

Global leaders announce new commitments to accelerate progress towards ending malaria deaths

Prominent leaders in global health and development joined several African heads of state at UN Headquarters today to announce new commitments to accelerate progress toward ending deaths from malaria, a disease that claims the lives of more than 850,000 Africans each year.

24 Sep 2010

Eastmont Community Center launches new adolescent immunization awareness initiative

Eastmont Community Center responded today to alarmingly low whooping cough and meningococcal meningitis immunization rates among Latino adolescents by launching a new adolescent immunization awareness initiative. The grassroots campaign aims to educate local Latino families about free or low-cost vaccines available to help protect children against these and other infectious diseases.

24 Sep 2010

New opportunity for hospitals to improve CA-BSI surveillance

A new study looking at how hospitals account for the number of pediatric patients who develop catheter associated bloodstream infections (CA-BSIs) found substantial inconsistencies in the methods used to report the number of patients who develop these infections.

24 Sep 2010

NIH awards grants to treat HIV/AIDS in criminal justice system

Twelve scientific teams in more than a dozen states will receive National Institutes of Health (NIH) grants to study effective ways to prevent and treat HIV/AIDS among people in the criminal justice system.

24 Sep 2010

Legislation to help speed research for cystic fibrosis and other rare diseases

Today the U.S. House of Representatives passed the "Improving Access to Clinical Trials Act" (I-ACT), in a victory for the Cystic Fibrosis Foundation, its advocates and 120 other health advocacy organizations.

24 Sep 2010

HIV-infected African Americans likely to develop kidney failure: Study

Among African Americans, HIV infection is increasingly recognized as an important risk factor for developing chronic kidney disease. African American men and women are more likely to die from the complications of HIV infection compared with Caucasian men and women.

24 Sep 2010

Cerus receives $1.4 million to support development of INTERCEPT red blood cell system

Cerus Corporation announced today that it has received an additional $1.4 million from the U.S. Department of Defense to support advanced development of the company's pathogen inactivation technology for red blood cells. The INTERCEPT red blood cell system is a pathogen inactivation product Cerus is developing to prevent the transmission of infectious diseases through red blood cell transfusions.

24 Sep 2010

Past exposure to pathogens leads to disease resistance spreading through populations

A study by researchers at Royal Holloway, University of London, University College London and Oxford University, has found that a genetic variant which reduces the chance of contracting diseases such as tuberculosis and leprosy is more prevalent in populations with long histories of urban living.

24 Sep 2010

Study: Non-stick coating substance in semen reduces HIV transmission

A non-stick coating for a substance found in semen dramatically lowers the rate of infection of immune cells by HIV a new study has found.

24 Sep 2010

Researchers discover molecular signature to predict TB infection

Dallas scientists recently discovered a molecular signature in the blood of patients with tuberculosis (TB) that may explain why some people develop an active TB infection, while others exposed to the bacteria which causes the dangerous respiratory virus do not.

24 Sep 2010

ASTMH recommends FDA to include neglected infections of poverty in orphan classification

Today, U.S. scientists committed to finding answers to reducing and eliminating what are known as neglected tropical diseases (NTDs) that plague the world's poorest people in developing countries, urged the FDA to include in its orphan classification the neglected infections of poverty that also affect Americans, and expressed support for stronger relationships with the FDA to ultimately halt these ancient scourges.

24 Sep 2010

New website offers real-life case studies and immunology breakthroughs on HIV

Amid a devastating HIV epidemic, some South African pediatricians treat as many as 100 children per day. With such overwhelming case loads, the physicians have little time to review the information they were offered in medical school on the topic of immunology. Recognizing the potential value of an understanding of up-to-date immunology in the treatment of HIV, immunologist Clive Gray developed Immunopaedia, a Web site that quickly and efficiently gives doctors a working knowledge of immunology through real-life case studies and news of immunology breakthroughs.

24 Sep 2010

Researchers identify mechanism that makes bacteria to resist antibiotics

A research team led by Edward Yu of Iowa State University and the Ames Laboratory has discovered the crystal structures of pumps that remove heavy metal toxins from bacteria, making them resistant to antibiotics.

24 Sep 2010

AJMS journal provides research update on new infectious pathogens

Newly recognized disease-causing viruses, bacteria, and other infections are continually emerging around the world, posing difficult challenges for patient diagnosis and treatment and for public health responses. A special symposium section of the September issue of The American Journal of the Medical Sciences (AJMS), official journal of the Southern Society for Clinical Investigation, provides a research update on important new infectious pathogens.

24 Sep 2010

Disease/Infection News

FDA approves OZURDEX implant for uveitis treatment

WA teenage death related to swine flu

Key pathway used by malaria parasite to infect human cells identified

Enobia announces positive results from ENB-0040 Phase II juvenile clinical trial for hypophosphatasia

Gore completes enrollment in study of VIABAHN Endoprosthesis with Heparin Bioactive Surface

3M announces series of educational events to combat healthcare-associated infections

Global leaders announce new commitments to accelerate progress towards ending malaria deaths

Eastmont Community Center launches new adolescent immunization awareness initiative

New opportunity for hospitals to improve CA-BSI surveillance

NIH awards grants to treat HIV/AIDS in criminal justice system

Legislation to help speed research for cystic fibrosis and other rare diseases

HIV-infected African Americans likely to develop kidney failure: Study

Cerus receives $1.4 million to support development of INTERCEPT red blood cell system

Past exposure to pathogens leads to disease resistance spreading through populations

Study: Non-stick coating substance in semen reduces HIV transmission

Researchers discover molecular signature to predict TB infection

ASTMH recommends FDA to include neglected infections of poverty in orphan classification

New website offers real-life case studies and immunology breakthroughs on HIV

Researchers identify mechanism that makes bacteria to resist antibiotics

AJMS journal provides research update on new infectious pathogens

How can microdialysis benefit drug development

Global and Local Efforts to Take Action Against Hepatitis

Addressing Important Cardiac Biology Questions with Shotgun Top-Down Proteomics

Latest News